#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Mark D'Ascenzo Email
Consultant . PreCyte
How to contact Mark D'Ascenzo
Join and see Mark's contact info for free!Current Roles
Employees:
4Revenue:
$620kAbout
PreCyte is developing the Indicator Cell Assay Platform (iCAP), a broadly applicable and inexpensive platform for blood-based diagnostics that can be used for early detection of disease, and as a companion diagnostic for drug development. The iCAP uses cultured cells as biosensors, capitalizing on the ability of cells to respond differently to signals present in the serum (or other biofluid) from normal or diseased subjects with exquisite sensitivity, as opposed to traditional assays that rely on direct detection of molecules in blood. Our first application is to Alzheimer's DiseasePreCyte Address
454 N 34th St, Seattle, WA, 98103Seattle, WA
United States